Skip to content
Episode 9: Randomisation in Clinical Trials episode artwork

Aug 20, 2025 12 min

Episode 9: Randomisation in Clinical Trials

from QCast: Data-Driven Dialogue in Drug Development Hosted by Quanticate

In this QCast episode, Jullia and Tom break down randomisation in clinical trials—why it matters, how different methods work, and what safeguards keep allocations fair and consistent across sites. They cover simple, block, and stratified randomisation, touch on unequal allocation and adaptive designs, and share a practical case study from a 5-arm trial. Key Takeaways Randomisation reduces bias, supports blinding, and strengthens trial validity. Simple, block, and stratified methods suit different trial sizes and needs. Unequal allocation and adaptive designs require clear rationale and oversight. Centralised systems keep assignments consistent and unpredictable across sites. Strong planning, role separation, and quality control ensure reliable execution. 🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & Management Biostatistics & Statistical Consultancy Statistical Programming & PK/PD Analysis Medical Writing & Pharmacovigilance Regulatory & Submission Support AI & Automation Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode details come from the podcast's RSS feed.

Embed this episode

In this QCast episode, Jullia and Tom break down randomisation in clinical trials—why it matters, how different methods work, and what safeguards keep allocations fair and consistent across sites. They cover simple, block, and stratified randomisation, touch on unequal allocation and adaptive designs, and share a practical case study from a 5-arm trial. Key Takeaways Randomisation reduces bias, supports blinding, and strengthens trial validity.Simple, block, and stratified methods suit ...

Ready to play

Episode 9: Randomisation in Clinical Trials

0:00 12:23

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of QCast: Data-Driven Dialogue in Drug Development?

This episode is 12 minutes long.

When was this QCast: Data-Driven Dialogue in Drug Development episode published?

This episode was published on August 20, 2025.

Can I download this QCast: Data-Driven Dialogue in Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.